DaVita Inc., 3SBio Inc. Partner to Provide Kidney Care in NE China

Published: Mar 09, 2012

DENVER & SHENYANG, China--(BUSINESS WIRE)--DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD) today announced it has entered into an agreement with 3SBio Inc., a leading Chinese biotechnology developer of biopharmaceutical products, to establish a joint venture for providing dialysis treatments in northeastern China.

Back to news